JN

Jayeshbhai Natwarbhai Patel

Director Director DIN 01723436
DIN 01723436 First appointment Sep 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayeshbhai Natwarbhai Patel

Data last updated:

Jayeshbhai Natwarbhai Patel was a Director at Epoch Pharmacuticals Private Limited (2007–2012) and Director at Eubiotic Pharmaceuticals Private Limited (from 2008). The companies operate in Pharma.

DIN 01723436
Primary Designation Director
Industry Pharma
First Appointment 14 Sep 2007
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epoch Pharmacuticals Private Limited U51397GJ2003PTC042563
Director14 Sep 20072003₹20.86 Cr (FY 2016)Active
Director03 Jul 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eubiotic Pharmaceuticals Private Limited
Epoch Pharmacuticals Private Limited
Premium access

Shareholding and investment profile for Jayeshbhai Natwarbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayeshbhai Natwarbhai Patel

Jayeshbhai Natwarbhai Patel was first appointed on 14 Sep 2007 as Director at Epoch Pharmacuticals Private Limited. The most recent appointment on record is 03 Jul 2008 at Eubiotic Pharmaceuticals Private Limited.

Jayeshbhai Natwarbhai Patel held 2 earlier board appointments: Epoch Pharmacuticals Private Limited (Director, 14 Sep 2007 to 27 Apr 2012); Eubiotic Pharmaceuticals Private Limited (Director, from 03 Jul 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available